Logo image of OPAD

OFFERPAD SOLUTIONS INC (OPAD) Stock Fundamental Analysis

NYSE:OPAD - New York Stock Exchange, Inc. - US67623L3078 - Common Stock - Currency: USD

1.03  -0.08 (-7.21%)

After market: 1.07 +0.04 (+3.88%)

Fundamental Rating

2

Overall OPAD gets a fundamental rating of 2 out of 10. We evaluated OPAD against 65 industry peers in the Real Estate Management & Development industry. OPAD may be in some trouble as it scores bad on both profitability and health. OPAD is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

OPAD had negative earnings in the past year.
In the past year OPAD had a positive cash flow from operations.
OPAD had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: OPAD reported negative operating cash flow in multiple years.
OPAD Yearly Net Income VS EBIT VS OCF VS FCFOPAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 200M -200M -400M -600M -800M

1.2 Ratios

The Return On Assets of OPAD (-19.86%) is worse than 73.85% of its industry peers.
With a Return On Equity value of -130.44%, OPAD is not doing good in the industry: 78.46% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -19.86%
ROE -130.44%
ROIC N/A
ROA(3y)-22.91%
ROA(5y)-14.91%
ROE(3y)-122.51%
ROE(5y)-74.49%
ROIC(3y)N/A
ROIC(5y)N/A
OPAD Yearly ROA, ROE, ROICOPAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

Looking at the Gross Margin, with a value of 8.28%, OPAD is doing worse than 73.85% of the companies in the same industry.
In the last couple of years the Gross Margin of OPAD has declined.
OPAD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.96%
GM growth 5YN/A
OPAD Yearly Profit, Operating, Gross MarginsOPAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5 -5 10

More info and screens

2

2. Health

2.1 Basic Checks

OPAD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OPAD has been increased compared to 1 year ago.
OPAD has a worse debt/assets ratio than last year.
OPAD Yearly Shares OutstandingOPAD Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
OPAD Yearly Total Debt VS Total AssetsOPAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 0.67, we must say that OPAD is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.67, OPAD is in line with its industry, outperforming 44.62% of the companies in the same industry.
OPAD has a debt to FCF ratio of 15.38. This is a negative value and a sign of low solvency as OPAD would need 15.38 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 15.38, OPAD is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
A Debt/Equity ratio of 4.98 is on the high side and indicates that OPAD has dependencies on debt financing.
With a Debt to Equity ratio value of 4.98, OPAD is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.98
Debt/FCF 15.38
Altman-Z 0.67
ROIC/WACCN/A
WACC8.66%
OPAD Yearly LT Debt VS Equity VS FCFOPAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M -200M -400M -600M -800M

2.3 Liquidity

A Current Ratio of 1.17 indicates that OPAD should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.17, OPAD is in line with its industry, outperforming 41.54% of the companies in the same industry.
OPAD has a Quick Ratio of 1.17. This is a bad value and indicates that OPAD is not financially healthy enough and could expect problems in meeting its short term obligations.
OPAD's Quick ratio of 0.32 is on the low side compared to the rest of the industry. OPAD is outperformed by 83.08% of its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 0.32
OPAD Yearly Current Assets VS Current LiabilitesOPAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

OPAD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.61%, which is quite impressive.
OPAD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.09%.
OPAD shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -23.72% yearly.
EPS 1Y (TTM)51.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.53%
Revenue 1Y (TTM)-30.09%
Revenue growth 3Y-23.72%
Revenue growth 5YN/A
Sales Q2Q%-27.52%

3.2 Future

OPAD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.90% yearly.
The Revenue is expected to grow by 19.49% on average over the next years. This is quite good.
EPS Next Y20.23%
EPS Next 2Y26.2%
EPS Next 3Y25.9%
EPS Next 5YN/A
Revenue Next Year6.17%
Revenue Next 2Y18.91%
Revenue Next 3Y17.98%
Revenue Next 5Y19.49%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OPAD Yearly Revenue VS EstimatesOPAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
OPAD Yearly EPS VS EstimatesOPAD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -2 -4 -6 -8 -10

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

OPAD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OPAD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OPAD Price Earnings VS Forward Price EarningsOPAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, OPAD is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1.84
EV/EBITDA N/A
OPAD Per share dataOPAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

OPAD's earnings are expected to grow with 25.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.2%
EPS Next 3Y25.9%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OPAD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OFFERPAD SOLUTIONS INC

NYSE:OPAD (5/5/2025, 5:54:50 PM)

After market: 1.07 +0.04 (+3.88%)

1.03

-0.08 (-7.21%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)02-24 2025-02-24/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners63.78%
Inst Owner Change-0.01%
Ins Owners18.94%
Ins Owner Change0.2%
Market Cap28.37M
Analysts74.55
Price Target2.28 (121.36%)
Short Float %5.68%
Short Ratio20.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.93%
Min EPS beat(2)-28.68%
Max EPS beat(2)-9.18%
EPS beat(4)0
Avg EPS beat(4)-25.63%
Min EPS beat(4)-35.67%
Max EPS beat(4)-9.18%
EPS beat(8)2
Avg EPS beat(8)-7.4%
EPS beat(12)3
Avg EPS beat(12)-14.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.12%
Min Revenue beat(2)-1.95%
Max Revenue beat(2)-0.3%
Revenue beat(4)1
Avg Revenue beat(4)-2.97%
Min Revenue beat(4)-13.18%
Max Revenue beat(4)3.54%
Revenue beat(8)3
Avg Revenue beat(8)2.49%
Revenue beat(12)6
Avg Revenue beat(12)4.72%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-18.26%
PT rev (3m)-42.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-62%
EPS NY rev (1m)0%
EPS NY rev (3m)-54.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-30.68%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-22.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF 1.84
P/OCF 1.36
P/B 0.6
P/tB 0.6
EV/EBITDA N/A
EPS(TTM)-2.26
EYN/A
EPS(NY)-1.8
Fwd EYN/A
FCF(TTM)0.56
FCFY54.38%
OCF(TTM)0.76
OCFY73.44%
SpS33.36
BVpS1.73
TBVpS1.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.86%
ROE -130.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.28%
FCFM 1.68%
ROA(3y)-22.91%
ROA(5y)-14.91%
ROE(3y)-122.51%
ROE(5y)-74.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.96%
GM growth 5YN/A
F-Score5
Asset Turnover2.94
Health
Industry RankSector Rank
Debt/Equity 4.98
Debt/FCF 15.38
Debt/EBITDA N/A
Cap/Depr 885.11%
Cap/Sales 0.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 0.32
Altman-Z 0.67
F-Score5
WACC8.66%
ROIC/WACCN/A
Cap/Depr(3y)337.52%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.21%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.53%
EPS Next Y20.23%
EPS Next 2Y26.2%
EPS Next 3Y25.9%
EPS Next 5YN/A
Revenue 1Y (TTM)-30.09%
Revenue growth 3Y-23.72%
Revenue growth 5YN/A
Sales Q2Q%-27.52%
Revenue Next Year6.17%
Revenue Next 2Y18.91%
Revenue Next 3Y17.98%
Revenue Next 5Y19.49%
EBIT growth 1Y59.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.41%
EBIT Next 3Y37.89%
EBIT Next 5Y20.79%
FCF growth 1Y-94.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-92.04%
OCF growth 3YN/A
OCF growth 5YN/A